Technical Analysis for ODT - Odonate Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 16.52 -0.72% -0.12
ODT closed down 0.72 percent on Friday, February 15, 2019, on 34 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical ODT trend table...

Date Alert Name Type % Chg
Feb 15 20 DMA Resistance Bearish 0.00%
Feb 15 Shooting Star Candlestick Bearish 0.00%
Feb 15 Bollinger Band Squeeze Range Contraction 0.00%
Feb 15 Down 3 Days in a Row Weakness 0.00%
Feb 14 20 DMA Resistance Bearish -0.72%
Feb 14 Bollinger Band Squeeze Range Contraction -0.72%
Feb 14 NR7 Range Contraction -0.72%
Feb 14 Earnings Movers Other -0.72%
Feb 13 20 DMA Resistance Bearish -1.43%
Feb 13 Bollinger Band Squeeze Range Contraction -1.43%

Older signals for ODT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
  • Earnings date: 2019-02-13
Odonate Therapeutics LLC is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.
Cancer Pharmaceutical Iowa Corcept Therapeutics Urbandale
Is ODT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 7 Odonate Therapeutics: Small Biotech Firm Seeks To Improve Quality Of Life For Breast Cancer Patients
Dec 31 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $835,107 of Shares
Dec 27 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $756,000 of Shares
Dec 20 The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Dec 19 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $586,800 of Shares
Dec 14 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $312,000 of Shares
Nov 27 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $258,967 of Shares
Nov 9 Consolidated Research: 2018 Summary Expectations for Senior Housing Properties Trust, NACCO Industries, Primo Water, Martin Marietta Materials, Iamgold, and Odonate Therapeutics — Fundamental Analysis, Key Performance Indications
Nov 6 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $148,700 of Shares
Nov 5 74 Biggest Movers From Friday
See more ODT news...
Indicators
Indicator Value
52 Week High 32.0
52 Week Low 11.54
Average Volume 66,812
200-Day Moving Average 19.0152
50-Day Moving Average 15.3688
20-Day Moving Average 16.807
10-Day Moving Average 16.718
Average True Range 0.7905
ADX 28.71
+DI 24.8922
-DI 14.4754
Chandelier Exit (Long, 3 ATRs ) 15.4785
Chandelier Exit (Short, 3 ATRs ) 18.1015
Upper Bollinger Band 17.5664
Lower Bollinger Band 16.0476
Percent B (%b) 0.31
BandWidth 9.036711
MACD Line 0.2888
MACD Signal Line 0.4076
MACD Histogram -0.1188
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.83
Resistance 3 (R3) 17.97 17.68 17.61
Resistance 2 (R2) 17.68 17.35 17.61 17.53
Resistance 1 (R1) 17.10 17.14 16.96 16.96 17.46
Pivot Point 16.81 16.81 16.74 16.74 16.81
Support 1 (S1) 16.23 16.48 16.09 16.09 15.58
Support 2 (S2) 15.94 16.27 15.87 15.51
Support 3 (S3) 15.36 15.94 15.43
Support 4 (S4) 15.22